Evidence map›Paper›PMID 36335230›Full record

ArticleAMB Express2022

Characterisation of marine bacterium Microbulbifer sp. ALW1 with Laminaria japonica degradation capability.

Zhipeng Li, Zeping Du, Hebin Li, Yanhong Chen, Mingjing Zheng, Zedong Jiang, Xiping Du, Hui Ni, Yanbing Zhu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AMB Express, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Characterization of a NaWorld journal of microbiology & biotechnology · 2025
    Article
  2. Article
  3. Article
  4. Polymer degrading marineBeilstein journal of organic chemistry · 2024
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zhipeng LiCollege of Ocean Food and Biological Engineering, Jimei University, Xiamen, 361021, China.
Zeping DuCollege of Ocean Food and Biological Engineering, Jimei University, Xiamen, 361021, China.
Hebin LiDepartment of Pharmacy, Xiamen Medical College, Xiamen, 361008, China.
Yanhong ChenCollege of Ocean Food and Biological Engineering, Jimei University, Xiamen, 361021, China.
Mingjing ZhengCollege of Ocean Food and Biological Engineering, Jimei University, Xiamen, 361021, China.
Zedong JiangCollege of Ocean Food and Biological Engineering, Jimei University, Xiamen, 361021, China.
Xiping DuCollege of Ocean Food and Biological Engineering, Jimei University, Xiamen, 361021, China.
Hui NiCollege of Ocean Food and Biological Engineering, Jimei University, Xiamen, 361021, China.
Yanbing ZhuCollege of Ocean Food and Biological Engineering, Jimei University, Xiamen, 361021, China. yanbingzhu@jmu.edu.cn.ORCID http://orcid.org/0000-0003-2771-1235
Jimei University · CNXiamen Medical College

Funding

National Natural Science Foundation of China 22038012National Natural Science Foundation of China 22178142Natural Science Foundation of Fujian Province 2020J01679
6 · The paper itself

Abstract

Marine bacterium Microbulbifer sp. ALW1 was revealed to be able to effectively degrade Laminaria japonica thallus fragments into fine particles. Polysaccharide substrate specificity analysis indicated that ALW1 could produce extracellular alginate lyase, laminarinase, fucoidanase and cellulase. Based on alignment of the 16 S rRNA sequence with other reference relatives, ALW1 showed the closest relationship with Microbulbifer aggregans CCB-MM1

Indexed as

Brown algaeComplete genome sequenceMicrobulbiferPolysaccharide degradationStrain characteristics

Identifiers

PMID36335230
PMCPMC9637087
OpenAlexW4308368680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.